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KAJIAN IN VITRO ANTIKULAT, ANTIOXIDANT DAN AKTIVITI   
SITOTOKSITI DARI Couroupita guianensis DENGAN PENGENALAN 
FRAKSI AKTIF ANTIKULAT 
 
ABSTRAK 
 
 Kajian ini telah dijalankan untuk menilai antikulat, antioksidan dan 
sitotoksiti aktiviti ekstrak bunga dari C. guianensis . Ekstrak ini dipilih daripada 125 
ekstrak tumbuhan perubatan tempatan dengan kaedah cakera resapan terhadap 
Streptococcus aureus , E. coli dan C. albicans. kajian ini didapati bahawa C. 
guianensis ekstrak bunga mempunyai spektrum aktiviti antimikrob yang luas. Cara 
pertumbuhan C. albicans dan peranannya dalam jangkitan manusia semakin menarik 
perhatian kerana rintangannya terhadap agen antikulat yang digunakan secara 
komersial. Oleh itu, kajian ini telah diteruskan untuk menentukan aktiviti anti-
Candida oleh ekstrak bunga C. guianensis. Ujian aktiviti anti-Candida telah 
dijalankan dengan menggunakan kaedah cakera resapan, kaedah pencairan kaldu dan 
profil membunuh mengikut masa. Kesan C. guianensis ekstrak bunga kepada 
struktur morfologi dan C. albicans telah diperiksa dengan mengimbas mikroskop 
elektron (SEM). Aktiviti anti-Candida menunjukkan bahawa zon min perencatan 
adalah 18.2 ± 0.3 mm. MIC dan nilai MFC untuk C. albicans didapati masing-
masing 12.5 mg/mL dan 25 mg/mL masing-masing . Keputusan kajian profil 
membunuh mengikut masa menunjukkan bahawa perencatan pertumbuhan C. 
albicans bergantung kepada kepekatan C. guianensis ekstrak bunga. Pengimejan 
SEM mendedahkan perubahan secara beransur-ansur dari masa ke masa pada 
mikrostruktur luar C. albicans. A kemusnahan lengkap C. albicans sel-sel telah 
xix 
 
diperhatikan selepas 36 jam terdedah kepada ekstrak bunga C. guianensis. 
Pengimejan SEM mendedahkan perubahan secara beransur-ansur dari masa ke masa 
pada mikrostruktur luar C. albicans. A kemusnahan lengkap C. albicans sel-sel telah 
diperhatikan selepas 36 jam terdedah kepada ekstrak bunga C. guianensis. Ekstrak 
bunga C. guianensis disaringkan untuk mengetahui komponen fitokimia dengan 
menggunakan kaedah piawai dan menunjukkan kehadiran bahan fitokimia seperti 
alkaloid, flavonoid, tanin, steroid, glikosida dan saponin. Jumlah kandungan fenolik 
dalam ekstrak bunga C. guianensis telah ditentukan dan didapati sebanyak 32.20 ± 
0.22 mg GAE/100 gram ekstrak. Kajian aktiviti antioksidan secara in-vitro telah di 
nilai dengan menggunakan kaedah asai hapus-sisa radikal bebas 2, 2-difenil-1-
pikrilhidrazil (DPPH) dan asai pemusnahan sisa radikal bebas hydrogen peroksida. 
Nilai IC50 ekstrak bunga C. guianensis ekstrak bunga untuk menghapus radikal bebas 
DPPH dan hidrogen peroksida masing-masing ialah 93.2 μg/mL ± 0.011 dan 46.48 ± 
0.13 μg/mL. Kesan sitotoksik daripada ekstrak bunga C. guianensis dinilai 
menggunakan ujian keracunan anak udang dan asai MTT. Sebatian dalam ekstrak 
bunga C. guianensis mepamerkan hasil bukan toksik dengan nilai LC50 = 1210.65 
μg/mL dan IC50 = 513.22 μg/mL. Kajian ketoksikan pada DNA dari ekstrak bunga 
C. guianensis bunga dinilai oleh gel elektroforesis (comet assay). Hasil kajian 
menunjukkan bahawa rawatan dengan ekstrak bunga C. guianensis tidak 
menyebabkan kerosakan DNA yang jelas dalam sel vero. Ekstrak bunga C. 
guianensis telah difraksinasi berturut-turut dengan heksan, etil asetat, butanol dan air 
untuk aktiviti anti-Candida dengan menggunakan kaedah cakera resapan. Fraksi etil 
asetat dianggap sebagai fraksi aktif berdasarkan nlai zon perencatan yang tinggi 
(18.9 mm). Fraksi aktif etil asetat yang mempamerkan aktiviti antikulat dianalisis 
dengan menggunakan kaedah kromatografi gas-jisim spektrometri (GC-MS). 
xx 
 
Analisis GC-MS menunjukkan kehadiran asid Docosanoic, asid n-heksadekanoat, 
asid Eikosanoat, benzamid, 2, 3, 4, 5-tetrafluoro-n(-3-methylthio-1, 2, 4-triazole-5- 
YL), asid 9, 12-Octadekanoat (Z, Z), asid Octadekanoat, asid Pentadekanoat, 14-
metil, Squalene dan asid  tetradekanoat di dalam fraksi aktif etil asetat yang mungkin 
bertanggungjawab tehadap aktiviti antimikrob  dan antikulat yang diperhatikan  
dalam kajian ini. Hasil kajian ini mencadangkan bahawa ekstrak bunga C. guianensis 
mempunyai aktiviti anti-candida dan antioksidan yang baik. Kajian lanjut diperlukan 
untuk mengenal pasti bahan fitokimia yang bertanggungjawab untuk aktiviti biologi 
dipamerkan dalam kajian ini. 
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IN VITRO EVALUATION OF ANTIFUNGAL, ANTIOXIDANT AND 
CYTOTOXICITY ACTIVITY OF Couroupita guianensis WITH THE 
IDENTIFICATION OF ANTIFUNGAL ACTIVE FRACTION 
 
ABSTRACT 
 
 The current study was undertaken to evaluate the antifungal, antioxidant and 
cytotoxicity activities of Couroupita guianensis flower extract.  The Couroupita 
guianensis flower extract was selected from 125 local medicinal plant by disc 
diffusion method against Streptococcus aureus, E. coli and C. albicans. It was found 
that the C. guianensis flower extract possessed a broad spectrum of antimicrobial 
properties. With respect to the emergence of susceptibility of C. albicans to 
antifungal agent, this study was conducted to determine the anti-Candida activity of 
C. guianensis flower extract. Anti-Candida test was carried out using disc diffusion 
assay, broth dilution method, and time killing profile. The effect of C. guianensis 
flower extracts upon the morphological and structure of C. albicans were examined 
by scanning electron microscope (SEM). Anti-Candida activity indicated that the 
mean zone of inhibition was 18.2 ± 0.3 mm. The MIC and MFC value for C. 
albicans found to be 12.5 mg/mL and 25 mg/mL respectively. Time kill experiments 
indicated an intense concentration-dependent fungicidal effect against C. albicans. 
Imaging of SEM revealed a gradual alteration over time on the outer microstructure 
of C. albicans. A complete destruction of C. albicans cells were observed after 36 
hours of exposure to flower extracts C. guianensis. Qualitative phytochemical 
screening C. guianensis flower extract showed the presence of alkaloids, flavonoids, 
tannins, steroids, glycosides and saponin. The Total phenolic content of the C. 
xxii 
 
guianensis flower extract was determined and exhibited moderate value with 32.2 ± 
0.22 mg of GAE/100 gram of extract. The free radical scavenging activity of C. 
guianensis flower extract was assessed by 2, 2-diphenyl-1-picryl hydrazyl (DPPH) 
radical scavenging assay and hydrogen peroxide radical scavenging activity. The 
IC50 values for C. guianensis flower extract for DPPH and hydrogen peroxide free 
radicals scavenging activities was 93.2 µg/mL ± 0.011 and 46.48 ± 0.13 µg/mL 
respectively. The cytotoxic effect of the C. guianensis flower extract was evaluated 
using brine shrimp assay and MTT assay. The compounds in C. guianensis flower 
extract exhibited non-toxic results with LC50= 1210.65 µg/mL and IC50= 513.22 
µg/mL.  Genotoxicity study on C. guianensis flower extract was assessed by the 
single cell gel electrophoresis (comet assay). Genotoxicity study results showed that 
treatment with C. guianensis flower extract did not cause obvious DNA damage in 
vero cells. The flower exract of C. guianensis was serially extracted with solvents of 
varying polarities, with hexane, ethyl acetate, butanol and water and tested for anti-
candida activity by disk diffusion method. Ethyl acetate fraction was regarded as 
active fraction on the basis of highest zone of inhibition (18.99 mm). The active 
ethyl acetate fraction were analysed with Gas Chromatography-Mass Spectrometry 
(GC-MS). The GC-MS analysis showed the presence of docosanoic acid, eicosanoic 
acid, n-hexadecanoic acid, benzamide, 2, 3, 4, 5-tetrafluoro-N(-3-methylthio-1, 2, 4-
triazol-5-yl), 9, 12-octodecadienoic acid (Z, Z), octadecadienoic acid, pentadecanoin 
acid, 14-methyl-, squalene and tetradecanoic acid in the ethyl acetate fraction which 
may responsible for observed antimicrobial and antifungal activities in this study. 
The results of this study suggested that C. guianensis flower extract possess good 
antifungal and antioxidant activity. Further study is required to identify the chemical 
compounds responsible for their biological activity.  
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CHAPTER 1.0: INTRODUCTION 
 
 
1.1 Overview 
The new-fangled drug resistance to human pathogenic fungus is repetitively being 
reported from all over the world (Piddock & Wise, 1989). Nonetheless, this situation 
is a threat in developing as well as developed countries (Pagano et al., 2006). 
Resistance to antifungal drug has taken to undesirable implication for mortality, 
morbidity and health care in the community. In Malaysia, HIV/AIDS cases have 
been reported since 1986 by the Ministry of Health (Naning & Kamarulzaman, 
2014). Since then, the number of patients with HIV positive has been increasing. In 
such condition, where patient‟s immune system is compromised, infections that are 
opportunistic such as cryptococcosis, penicilliosise and candidiasis are common 
(Shai et al., 2008). Indirectly, fungal infection holds a critical problem to health and 
major root for mortality worldwide. Despite the increase in the spectrum of 
antifungal agents, the antifungal regimen has fallen far behind bacterial 
chemotherapy (Duraipandiyan & Ignacimuthuthe, 2011). For instance, Amphotericin 
B is a macrocyclic type compound and is used as “gold standard” for being less 
toxic. It was made available in the early 60‟s and prescribed until now. Griseofulvin, 
terbinafine and itraconazole are considered as drug of choice for fungal infections. 
Unfortunately, these drugs have been withdrawn from market as it has been 
superseded by new antifungal drugs (Abad et al., 2007). 
 Regardless of dedication to the development of new therapeutic 
strategies, there are only a limited number of available drugs to fight against fungal 
infections. Indeed, only four molecular classes that target three distinct fungal 
2 
 
metabolic pathways are currently used in clinical practice to treat essentially fungal 
infections: fluoropyrimidine analogs, polyenes, azoles, and echinocandins. Several 
other classes, such as morpholines and allylamines are only used as topical agents 
due to poor efficiency or several adverse effects when administered systemically. 
Thus the choice of suitable antifungal agents remains relatively limited due to the 
emergence of resistant fungal species and infection breakthrough (Pasqualotto & 
Denning, 2008).  
Ignorance of the antifungal drug‟s drawback added more to the existing 
complexity. Health care providers have often overlooked this problem; being if one 
antifungal did not treat the infection, another was usually available. Coupling to this 
problem, the undesirable side effects of long term treatment including 
hypersensitivity, allergic reaction and immune-suppression pose a real challenge to 
their clinical use. This fact is supplemented with slow mycological diagnosis, 
variable drug bioavailability in immunocomprimised patients and lack of either oral 
or intravenous preparation. Since then, doctors and nurses are facing with treat 
infection where antibiotic options are very finite (Ponnusamy et al., 2010). 
 The increase in the prevalence of multiple drug resistance has slow down the 
development of new synthetic antifungal drugs. A new synthetic antifungal drug may 
have a limited time in which fungal may develop resistance. This situation has forced 
scientist to search for novel compound with different mode of action (Monroe & 
Polk, 2000). Therefore, a search for novel antifungal drugs selectively acting on new 
targets with fewer or no side effects is extremely necessary. Against this backdrop, 
researchers are forced to identify and explore a non-chemical, non-classical approach 
which is plant-based therapeutic agents that are cheaper, safer and effective 
antifungal drugs (Suleiman et al., 2010). 
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1.2 Plant as antifungal agent 
Medicinal plants rich in natural sources have been used to treat mankind for various 
diseases since antiquity. The utilization of crude extracts of plant parts and 
phytochemicals for treating diseases is as old as the human species. Popular 
observations on the use and efficacy of the medicinal plants significantly contribute 
to the discovery of their therapeutic properties, so that they are frequently prescribed, 
even if their chemical constituents are not always completely known.  Moreover, 
phytotherapies assures a shorter and cheaper manufacturing as medicinal plant does 
not demand for a strict quality control concerning safety and effectiveness compared 
to the synthetic drugs (Maregesi et al., 2008). 
 Medicinal plants appeared to be an excellent system of antimicrobial 
therapeutic agent compared to western medicine because of their limitless 
availability and affordability. Plants are capable of synthesizing secondary chemical 
substances which play a pivotal role in their ecophysiology, counting a safeguarding 
role against herbivores, pathogen attack and play an attractant role against beneficial 
organisms such as symbionts (Briskin, 2000). Thus, potential secondary-derived 
compounds may therefore have beneficial goods in combating microbial infections in 
animals and humans (Suleima et al., 2010). 
 Generally, plants produce secondary metabolite which exhibits 
antibacterial, antifungal and insecticidal with minimal environmental impact and not 
toxic to human cells in contrast to the synthetic antifungal agent. Thus, the health 
risk by using medicinal plant is minimized (Pathwardhan, 2004). Plant system is less 
complicated than other bio-sources like animals, so the purification and extraction 
techniques for the antifungal agent are less complicated. Moreover, plants are 
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considered as an excellent system because of their ability to regulate human protein 
expression for palliation of a disease. Besides, identification of phyto-compounds in 
plants can significantly contribute to the development of plant crops by altering crop 
genetics with aim to enhance durable resistance mechanisms in crop plants against 
pathogens (Verma & Dubey, 1999). 
Medicinal plant either as pure compounds or extracts, present boundless 
prospect for new therapeutic agent by reason of the unmatched availability of 
chemical diversity in plant group (Cos et al., 2006). Their distinctive chemical 
structures differ from those synthetic antimicrobial drugs and hence their modes of 
action are most likely to vary. This expands the interest in phytochemical 
constituents of medicinal plant with its pharmacological activity (Roy et al., 2009). 
For these reasons, medicinal plant that is traditionally used by local population in 
Malaysia has been chosen as source of medicinal plant for antifungal agent 
development in this study.  
1.3 Problem statement 
Malaysian medicinal plants have played a significant role in traditional medicine 
among local people and also have been consuming medicinal plant as the dietary 
intake since ancient times. Due to emergence of antifungal drug resistance, lack of 
curative effect, high cost and toxicity, a new prototype antifungal agent is needed to 
address this situation (Nostro et al., 2000). This urged the evaluation of medicinal 
plants as a source of potential antifungal agent based on their usage as therapeutic 
agents. It is postulated that a naturally produced agent, Couroupita guianensis flower 
extract could fill this need as this flower was reported to be rich in phytocompounds.  
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1.4 Objectives  
The current study was conducted with the following objectives: 
1. To screen for antimicrobial activity of the 125 of local medicinal plants. 
2. To evaluate the anticandidal activity of C. guianensis flower extract against 
C. albicans. 
3. To evaluate the antioxidant activity of C. guianensis flower extract. 
4. To determine the in-vitro cytotoxicity and genotoxicity of C. guianensis 
flower extract. 
5. To identify the active anticandidal fraction from C. guianensis flower extract. 
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CHAPTER 2: LITERATURE REVIEW 
 
 
2.1 Medicinal plants 
2.1.1 Introduction  
Traditional medicine refers to indigenous or folk medicine incorporating the use of 
plant and their components to treat diagnose and prevent illness or maintain well-
being. Traditional medicine combines health practices, knowledge, beliefs and 
integrates plant and mineral based medicines to treat, diagnose and prevent illnesses 
or maintain well being (Lulekal et al., 2008). Plants are considered as medicinal if 
they are collected only for their therapeutic use. Examples of plants derived 
medicines which serve as new source for drugs and this includes theophylline from 
Chinese tea (bronchodilators), morphine from poppies (pain inhibitors) and 
vincristine from periwinkle (antineoplastic) (Licciardi & Underwood, 2011).  
Medicinal plants contain components of therapeutic value have continued to 
play a dominant role in the maintenance of human health for centuries (Nair et al., 
2005). Plant extract or their active compounds are used in traditional therapies of 
80% of the world‟s population. The diverse range of active compound or bioactive 
molecules makes them a rich source of different types of medicines. Today, a great 
number of different medicinal plant products are available on market including 
pharmaceuticals and cosmetics. Example is the latest discovery of a new cancer-
killing compound, taxol which is originate from the Pacific Yew tree (Nahrstedt et 
al., 2000). There has been revival of interest in herbal medicines compared to 
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modern conventional pharmaceuticals partly due to usage of herbal medicines lower 
the incidence of adverse reactions and reduced cost with strong biological activity. In 
addition, the limited ability of synthetic pharmaceutical products to control major 
disease has increased the awareness among many scientists and encouraged them to 
screen plants to study the biological activity of their constituents in therapeutic 
aspects (Sies et al., 1996).  
2.1.2 Phytochemistry of medicinal plants 
The beneficial of medicinal plant result from the secondary metabolites present in the 
plant. The medicinal actions of a plant are specific to particular species or group as 
the presence of secondary metabolites in a particular plant are distinct consistent with 
their taxonomical classification (Wink, 1999). Secondary metabolites have been 
defined historically as a chemical without any pivotal role contradicting to primary 
metabolites (carbohydrates, lipids, protein and nucleic acid) which are common to all 
plants and involved in primary metabolic process of building and maintaining plant 
cell (Kaufman et al., 1999).  
Recent research has also revealed that secondary metabolites have protective 
roles in relation to pathogen attack, inter-plant competition, abiotic stress linked with 
changes in temperature, water status, light level, UV exposure and mineral nutrients. 
Potential role of secondary metabolites at cellular level were also reported plant as 
growth regulators, modulators of gene expression, and in signal transduction 
(Kaufman et al., 1999). Secondary products have a variety of ecological functions in 
plants such as protects plants from being infected by microbial pathogens and as 
agents of plant-plant competition and plant-microbe symbioses which are likely to 
have bearing on potential medicinal effects for humans. For an example, secondary 
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products involved in plant defence through cytotoxicity towards microbial pathogens 
could serve as antimicrobial agent in humans, if not too toxic. Similarly, secondary 
metabolites involved in defence against herbivores through could act as 
antidepressants, sedatives, muscles relaxants, or anaesthetics in humans (Wink & 
Schimmer, 1999). In this regard, the secondary plant product may exert their action 
in human as endogenous metabolites, hormones or signal transduction molecules to 
combat diseases in human (Kaufman et al., 1999).  
2.1.3 Major phytochemical groups of antimicrobial activity 
Phytochemical constituents are compounds that present in the plant which lead to the 
pharmacological properties of the plant. These compounds are recognised as 
secondary metabolites and can be classified based on composition (presence or 
absence of nitrogen, chemical structure (contain ring or sugar), the pathway which 
they are synthesized or their solvent solubility (Agrawal & talele, 2011). A basic 
classification of secondary metabolites includes terpenoids, phenolic and nitrogen 
containing compound, nitrogen and sulphur containing compound. Chemical analysis 
showed most plant is presented with flavonoids and phenolic together with their 
derivatives (Rafael et al., 2008). Table 2.1 shows the most common secondary 
metabolites in plants.  
 Antimicrobial phytochemicals can be categorized into several groups. Simple 
phenols and phenolic acids simplest are bioactive phytochemicals consist of a single 
substituted phenolic ring. Phenolic compounds holds a C3 side chain at a lower level 
of oxidation and containing no oxygen often cited as antimicrobialCinnamic and 
caffeic acids are most common examples of a widespread group of phenylpropane 
derived compounds considered bacteriostatic against both fungi and bacteria 
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(Pengelly, 1996). Quinones are aromatic rings with two ketone substitutions. They 
are ubiquitous in nature and are responsible for the browning reaction in cut or 
injured fruits and vegetables. Quinones are excellent source of stable free radicals 
and had potential antimicrobial effects (Kazmi et al, 1994).  
 Flavones, flavonoids, and flavonols are derivates phenolic structures 
containing carbonyl group. They are reported to be synthesized in response to 
microbial infection by plants. Also said, they have been establish in-vitro to be 
effective antimicrobial compound against a wide range of microorganisms 
(Tsuchiya, 1996). Tannins are categorized into two groups, hydrolyzable and 
condensed tannins and are substance capable of tanning leather or precipitating 
gelatin, also known as astringency properties. Their mode of antimicrobial action is 
by inactivation of microbial adhesins, enzymes and cell envelope transport proteins 
(Jones et al., 1994). Alkaloids are heterocyclic nitrogen compounds. The mechanism 
of action of highly aromatic alkaloids is their ability to intercalate with DNA. 
Reports mention that they are potentially effective against trypanosomes and 
plasmodia (Phillipson et al., 1987).  
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Table 2.1: Major groups of secondary metabolites in plant 
Class Example Compounds Example Sources 
Nitrogen containing  
Alkaloids 
Nicotine, cocaine, theobromine Tabacco plant, cocao 
Nitrogen and sulphur 
containing 
Glucosinolates 
 
Sinigrin 
 
Cabbage, relatives 
Terpenoids 
Monoterpenes 
Diterpenes 
Triterpenes, cardiac,glycosides 
Tetraterpenoids 
Terpene polymers 
Sterols 
 
Menthol linalool 
Gossypol 
Digitogenin 
Carotene 
Rubber 
Spinasterol 
 
Mint and relatives, many plants 
Cotton 
Gigitalis (foxglove) 
Carrots, sweet potato, mangoes 
Hevea (rubber) trees,dandelion 
Phenolics 
Phenolic acids 
Coumarins 
Flavonoids 
Tannin 
 
Caffeic, chlorogenic 
Umbelliferone  
Anthocyanin, catechin 
Gallotannin, condensed tannin 
 
In all plants 
Carrots, parsnip 
All plants 
Oak, hemlock trees 
(Adapted: Cowan, 1997) 
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2.2 Biodiversity prospect of medicinal plant in Malaysia 
2.2.1 Country profile  
Malaysia consists of Peninsular Malaysia and east Malaysia, the states of Sabah and 
Sarawak separated by South China Sea into two similarly sized region with total 
landmass of 329, 847 sq km. It consists of thirteen states and three federal territories. 
Malaysia is expected to become 43
rd
 most populous country in the world by 2015 
with a population of over 30 million (U.S and world population clocks, 2014). 91.8% 
of total population are Malaysian citizen, with the Malay counting 63.1% being the 
predominant ethnic group in Peninsular Malaysia while the Ibans constituted 30.3% 
of the total citizens in Sarawak while Kadazan/Dusun made up 24.5% in Sabah. 
Malaysia is multi-racial, multi-cultural and multi-religious country with Malay, 
Chinese and Indian ethnic groups (John and Brownsey, 1988).   
2.2.2 Use of medicinal plant in Malaysia 
Malaysia has a unique locality which is diverse in climate, geology and geography. 
Though Malaysia is relatively a small country, it is characterized by a great variation 
in wild plants. Malaysia has around 3200 wild plant species, of which 100 species 
are endemic, belonging to about 700 genera. From these plants, more than 1200 
species are categorized as medicinal plants which is broadly scattered all over the 
country and enormously used in traditional medicine. In addition to this unique 
botanical heritage, traditional healing is integral to each ethnical group (Ibrahim, 
2004).  
In Malaysia, traditional health practices involving the use of remedies derived 
from plants are common and widespread such that 60-80% of the population belief 
and culture relies solely or partially on such practices to treat a variety of mild 
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diseases. Apart from their cultural significance, these medicines are generally more 
accessible and affordable. These medicines plants are used in Malaysia for different 
biological and pharmaceutical activities including antifungal, antibacterial and 
insecticidal properties (DeSmet, 1997). A study conducted in Malaysian population 
analysing the utilization between traditional and modern medicine revealed that 41% 
of participant using traditional medicines was much higher compared to previous 
years (Jamia, 2006) An increasing utilization by every year, point towards the 
awareness of the people on the safety and efficiency of plant medicine utilization 
containing natural compounds for ailment (Zabidah et al., 2005). This reliance on 
plants as source of medicines warrants scientific validation of their safety, efficiency, 
quality and the appropriate dosage of the plant material used (Masika & Afolayan, 
2002).  
2.2.3 Disease transition in Malaysia 
Occurrence of disease in Malaysia is a fragment of a complex interaction between 
humans and their social and physical environment. From the time when 
independence, the Malaysian healthcare system has provided great and valuable 
service to Malaysia via a broad network of both public and private facilities. 
Malaysia as a developing country is experiencing a rapid socio-economic growth in a 
much shorter time, gaining to an extent the experience of the developed world. 
Accessible through 349 hospitals (140 government & 209 private), 7700 clinics with 
doctors (public & 6675 private) and 2009 community clinics run by paramedics 
(klinink Desa), the Malaysian healthcare has improved over the years with doctors to 
patient ratio from 1:1437 to 1:758. This transition proposes that as people 
revolutionise with age, the balance between death and disease also changes. The 
expectancy in gradual changes of infectious disease to more chronic is predicted. 
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Since the state of nation‟s health has economic value, the sickness due to infectious 
diseases is a calculable economic loss to the community (Ledergerber, 1990).  
With the introduction of socio-economic development, the common cause of 
mortality has shift from poverty and underdevelopment related communicable 
microbial disease such as malaria, tuberculosis, gastroenteritis to modernisation 
related diseases such as hepatitis, gonorrhoea and syphilis. These diseases that were 
relatively unrecognised in the past are increasingly being identified. These incidences 
of disease are most commonly transmitted sexually. Currently, sexually transmitted 
disease (STI) is the leading or top infectious killer in Malaysia. Untreated STI may 
lead to severe physical and psychosocial morbidity and mortality. More importantly, 
such infections have been shown to enhance the transmission and/ or acquisition of 
HIV. With the recent increase of STI(s), this may lead to an increase in the number 
of patient infected with Human immunodeficiency virus/Acquired immunodeficiency 
syndrome (HIV/AIDS) (Fleming & Wasserheit (1999). 
2.3  Opportunistic fungal infection associated with HIV/AIDS in Malaysia 
Acquired immunodeficiency syndrome or more generally known as AIDS is a 
critical public health concern. Scientific resources supports that HIV is the causative 
agent of AIDS (Alizon et al., 2010). HIV is viruses that alter the host immune 
system, making them more vulnerable to secondary infections and disease. HIV is 
found in the infected human body fluid including semen, vaginal fluids, and blood 
and breast milk. The virus is passed either via sexual intercourse, injection drug use, 
occupational exposure and blood transfusion (Khobotlo, 2009). Symptoms may be 
developed shortly after being infected, being nausea, vomiting, reduced appetite, 
weight loss, headache, diarrhoea, constipation, anxiety and depression. Despite the 
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ready access to antiviral therapy and conventional treatments for secondary or 
opportunistic infections, The demand for alternative HIV medicine for addressing 
drug resistance, to prevent or relieve treatment side effect, some of which are not 
easily treatable with conventional medicine. Adding to complementary therapies 
assets are immunity booster, stress reliever or to improve general health or wellbeing 
(Woolridge et al., 2005).  
Malaysia has become home to one of the fastest growing AIDS epidemics in 
the East Asia and Pacific region. Malaysia HIV/AIDS cases have been detected since 
1986. From 1986 till 2012, 101,672 men, women and children have been confirmed 
with HIV and 16,360 deaths have been reported. Males make up the majority of HIV 
cases (90%), but the percentage of women reported with HIV increased greatly in the 
last decade, from 4% of new cases in 1995 to 12% in 2005 and 18% in 2011 (Masur, 
2014).  
The causative agent or the virus of AIDS infects the cells of the immune 
system. HIV can infect multiple cells in the patient, but its main target is the CD4 
lymphocytes, also known as T-cell or CD4 cell. CD4 cells are a type of white blood 
cell (WBC) which is part of infection fighting immune system (Catalfamo et al., 
2008). Once infected with HIV, the virus instigates the attack and destruction of the 
CD4 cells of infected person affecting the CD4 count in the body. As the infection 
progress, the number of CD4 cells decline with the strength of immune system. At 
advanced stage of HIV infection, people are vulnerable to secondary infections and 
malignancies that are generally termed as opportunistic infections (). 
People with healthy immune system can be exposed to bacteria, fungus or 
bacteria, would not produce any significant disease. Contrasting to people living with 
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HIV/AIDS can face serious health threats when there are exposed to opportunistic 
infections as their immune system have been suppressed and cannot fight disease. 
These infections are called “opportunistic” as they benefits of only from weakened 
immune system and resulting in distressing illness (Benson et al., 2005).  
Fungal infection accounts for a large number of AIDS-index diagnosis and 
complicate the course of most patients with HIV/AIDS disease compared to other 
microbial pathogen in Malaysia. Table 2.3 list the most common occurrence of 
microbes in HIV patient among Malaysian. Fungi are said to be the common and 
difficult to avoid because they are natural part of environment or more commonly 
known as normal flora. They are also found outdoors such as in soil, on plants, trees 
and other vegetation. Besides, they also present on the surface of human skin 
(Romani, 2008).  
Opportunistic fungal infections continue to be associated with high mortality 
and morbidity. Comparing to most bacterial infections, diagnosis of fungal infection 
is not an easy task. Fungi are a slow growing and difficult to identify. Unlike for 
bacterial infection, the serum concentrations of most antifungal agents are not 
routinely examined. Due to the poor knowledge, the relationship between plasma 
concentration, susceptibility and clinical effectiveness is still unidentified. Adding to 
the high prevalence of fungal infection in HIV/AIDS is the range and diversity of 
fungi that causes the disease to broadened (Pappas, 2006).The emergence of drug 
resistance towards the existing antifungal agent correspondingly become the cause of 
death among HIV/AIDS patients (Pappas et al., 2009).  
The most common fungal infection seen in association with HIV infection is 
candidiasis and represent a major threat to HIV/AIDS infected people (Morgan, 
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2005). Candidiasis is a disease caused by genus Candida, predominately by Candida 
albicans. C. albicans produce wide array of disease ranging from superficial, 
mucocutaneous to invasive infection. They can be found in the mouth, skin, scalp, 
vagina, fingers, nails (superficial), bronchi, lung or gastrointestinal tract 
(mucocutaneous) and may progress to systemic circulation where they are found in 
blood, consequences can be deadly (Badiee, 2011).  
Infection of dermal candidiasis can involve almost any skin on the body. 
Rashes from candidiasis can appear either as white or red skin. The common site for 
candidiasis is areas of skin that are moist o sweaty. Therefore the common sites 
affected are in fold of skins, groin, and armpits and around the breast area (Pappas et 
al., 2009). Oropharyngeal candidiasis is asymptomatic. Patient‟s maybe be presented 
with either soreness or burning sensation in the mouth and throat (Johnson, 2000). 
Patients with genital, vaginal candidiasis may experience an itchy rash on the 
affected area, white, discharge, and soreness (Umeha & Umeakanne, 2010). Figure 
2.1 shows most common infected area of candidiasis.  
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Figure 2.1: Clinical manifestation of candidiasis; upper left: dermal candidiasis,  
        upper right: oral candidiasis, lower left: oropharyngeal candidiasis, lower  
        right: genital candidiasis. (Adapted: Pfaller, 2006) 
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Table 2.2: Microbial profile of HIV positive in Malaysia 
Pathogens No of cases (%) 
Bacterial respiratory pathogens 
Mycobacterium tuberculosis 
Klebsiella pneumonia 
Pseudomonas spp 
Staphylococcus aureus 
Escherichia  coli 
 
23 
6 
4 
3 
2 
Fungal pathogens 
Candida albicans 
Candida tropicalis 
Candida Krusie 
Cryptococcus neoformans 
 
27 
5 
1 
2 
Intestinal parasites 
Cryotosporidium 
Isospora beli 
Giardia lamblia 
Entamoeba histolytica 
Lodoamoeba butschii 
 
20 
3 
2 
1 
1 
(Adapted: Koh, 2014) 
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2.4 Genus candida  
Genus Candida consists of 150-200 species. C. albicans is one of the most common 
species in medical practice (Pfaller & Diekema, 2002). In general, these organisms 
are isolated from the oral cavity, epidermis, genital and gastrointestinal tract in 
healthy humans as microflora. The immune system keep a balance from other 
microorganism from enviroment or the microflora itself from becoming pathogenic 
in healthy people. However, a weak immune system as in HIV/AIDS makes it easier 
for microorganism such as C. albicans to grow and cause infection. A serious 
outbreak occur when CD4 count are decline up to 100 and below. Normal range of 
CD4 count in healthy humans is above 500 cells/mm
3
. At this point, candidiasis can 
persist and difficult to be treated (Rautemaa et al., 2006). Although there are over 
200 species of Candida, only few species have been associated with human disease 
as listed in table 2.3. 
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Table 2.3: The medically significant Candida species 
Pathogenic species 
Candida albicans (50-60 %) 
Candida parapsilosis (10-20 %) 
Candida glabrata  (15-20 %) 
Candida tropicalis (6-12 %) 
Candida rusei (1-3 %) 
Candida kkefyr( ≤ 5%) 
Candida lusitaniae (≤ 5%) 
(Adapted: Pfaller & Diekema, 2002) 
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2.4.1 Polymorphic species 
C. albicans is a polymorphic fungus, ranging from unicellular budding yeast to true 
hyphae with parallel side wall. The cell wall structure ultimately responsible for 
given morphology. They grow either as yeast with budding ovoid-shaped or 
pseudohypae with elongated cell with constriction at the septa. C. albicans 
reproduces by budding to form unicellular yeast cell (blastospores). The hypae 
(mycelial form) are the germ tubes that result from a filamentous growth (Sudbery et 
al., 2004). Pseudohypae is formed when the blastopores elongate without 
detachment. Under non-optimal condition, C. albicans can also form 
chlamydospores, which are round, refractile spores with thick cell wall as shown in 
Figure 2.2 (Lo et al., 1997).  
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Yeast cell with blastospores 
 
 
 
Pseudohypae 
 
 
 
True hypae 
 
 
Chlamydospores 
Figure 2.2: The various cell types of C. albicans, each with different roles in growth 
                    and disease in the human host (Adapted Neil, 2013).  
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The ability to switch morphologically represents a response to undesirable 
changes in the environmental condition and adaptation to different biological niche. 
A range of environmental cues affect C. albicans morphology including response to 
pH, physiological temperature, CO2 and starvation. The production of unicellular 
yeast form is triggered by low temperature, low pH (acidic condition) and high 
glucose concentration (Whiteway & Bachewich, 2006). At high pH (>7) and 
temperature, low concentration of glucose (starvation), hypal growth is induced. 
Yeast cell are have important roles in establishing and disseminating Candida 
infections, whereas hypae are responsible for tissue penetration and invasion (Neil, 
2013). Yeast cell have different properties than hypae as the biological attributes, 
ultrastructure and the composition of the cell wall contrast each other. According to 
Yang (2003), mutant cells, lacking genes coding for the ability to switch cell type are 
less virulent. The ability to switch between various morphological forms is an 
important feature of C. albicans to infect and survive in the human host (Kurtz et al., 
1990).  
2.4.2 Cell wall composition and plasma membrane of C. albicans 
The cell wall of C. albicans is composed of 80-90% carbohydrates and 10% proteins. 
The polysaccharides of the cell wall represented by three basic constituents including 
mannans, β-glucons and chitins. In addition the cell walls contain minor amount of 
lipids (1-7%). The structural component of the cell wall represented by β-glucons 
and chitins (microfibrillar polymers). They serve as a solid skeleton that function as 
strong physical protection to the cell. Mannan (mannose polymer) represents 40% of 
the total cell wall polysaccharide and the main component of matrix cell wall 
(Cassone, 1989). The cell wall composition between the yeast and hyphae vary 
according to the C. albicans growth phase (Klis et al., 2001). The hyphal cell holds 
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more chitin than yeast cell. Immature hyphal cell more contain β-glucons than that 
found in mature hyphal. Chittin and β-glucons are mainly present in inner cell wall 
and mannons are present in the outer layer (Sullivan et al., 1983). 
 The selectively permeable plasma membrane is required by C. albicans for 
survival. It contains glycolipids, sphingolipids, sterols and free fatty acid. The lipid 
bilayer of plasma membrane comprised with ergosterol instead of cholesterol. Both 
yeast and hyphae contain ergosterol. This sterol provides a useful target in the 
development of antifungal agent. As for the lipid content of the plasma membrane, 
the composition can vary according to the changes of duration of biofilm, pH, 
oxygen pressure, host substrate and presence of antifungal agent (Baek et al., 2006).  
 
